As the opioid crisis has unfolded concerns have grown about dependency and the potentially addictive nature of opioid-based pain treatments. Having satisfactory non-opioid treatment alternatives will need to be an integral part of effective pain management.
Tanezumab’s Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments
